
|Articles|May 1, 2003
Consider efficacy, effectiveness, safety to prove all-around value of a drug
Author(s)Mari Edlin
FMCP model urges plans to think outside the cost silo when making formulary decisions
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
Cancer survival fell and deaths rose during first two years of COVID-19
3
TrumpRx launches; some experts question its long-term value
4
PBM reform. It has finally happened
5























